Cargando…

EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19

Detalles Bibliográficos
Autores principales: Salmanton-García, Jon, Busca, Alessandro, Cornely, Oliver A., Corradini, Paolo, Hoenigl, Martin, Klimko, Nikolai, Marchesi, Francesco, Pagliuca, Antonio, Passamonti, Francesco, Koehler, Philipp, Pagano, Livio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232068/
https://www.ncbi.nlm.nih.gov/pubmed/34235404
http://dx.doi.org/10.1097/HS9.0000000000000612
_version_ 1783713557174550528
author Salmanton-García, Jon
Busca, Alessandro
Cornely, Oliver A.
Corradini, Paolo
Hoenigl, Martin
Klimko, Nikolai
Marchesi, Francesco
Pagliuca, Antonio
Passamonti, Francesco
Koehler, Philipp
Pagano, Livio
author_facet Salmanton-García, Jon
Busca, Alessandro
Cornely, Oliver A.
Corradini, Paolo
Hoenigl, Martin
Klimko, Nikolai
Marchesi, Francesco
Pagliuca, Antonio
Passamonti, Francesco
Koehler, Philipp
Pagano, Livio
author_sort Salmanton-García, Jon
collection PubMed
description
format Online
Article
Text
id pubmed-8232068
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-82320682021-07-06 EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19 Salmanton-García, Jon Busca, Alessandro Cornely, Oliver A. Corradini, Paolo Hoenigl, Martin Klimko, Nikolai Marchesi, Francesco Pagliuca, Antonio Passamonti, Francesco Koehler, Philipp Pagano, Livio Hemasphere Editorial Lippincott Williams & Wilkins 2021-06-25 /pmc/articles/PMC8232068/ /pubmed/34235404 http://dx.doi.org/10.1097/HS9.0000000000000612 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Salmanton-García, Jon
Busca, Alessandro
Cornely, Oliver A.
Corradini, Paolo
Hoenigl, Martin
Klimko, Nikolai
Marchesi, Francesco
Pagliuca, Antonio
Passamonti, Francesco
Koehler, Philipp
Pagano, Livio
EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19
title EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19
title_full EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19
title_fullStr EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19
title_full_unstemmed EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19
title_short EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19
title_sort epicovideha: a ready to use platform for epidemiological studies in hematological patients with covid-19
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232068/
https://www.ncbi.nlm.nih.gov/pubmed/34235404
http://dx.doi.org/10.1097/HS9.0000000000000612
work_keys_str_mv AT salmantongarciajon epicovidehaareadytouseplatformforepidemiologicalstudiesinhematologicalpatientswithcovid19
AT buscaalessandro epicovidehaareadytouseplatformforepidemiologicalstudiesinhematologicalpatientswithcovid19
AT cornelyolivera epicovidehaareadytouseplatformforepidemiologicalstudiesinhematologicalpatientswithcovid19
AT corradinipaolo epicovidehaareadytouseplatformforepidemiologicalstudiesinhematologicalpatientswithcovid19
AT hoeniglmartin epicovidehaareadytouseplatformforepidemiologicalstudiesinhematologicalpatientswithcovid19
AT klimkonikolai epicovidehaareadytouseplatformforepidemiologicalstudiesinhematologicalpatientswithcovid19
AT marchesifrancesco epicovidehaareadytouseplatformforepidemiologicalstudiesinhematologicalpatientswithcovid19
AT pagliucaantonio epicovidehaareadytouseplatformforepidemiologicalstudiesinhematologicalpatientswithcovid19
AT passamontifrancesco epicovidehaareadytouseplatformforepidemiologicalstudiesinhematologicalpatientswithcovid19
AT koehlerphilipp epicovidehaareadytouseplatformforepidemiologicalstudiesinhematologicalpatientswithcovid19
AT paganolivio epicovidehaareadytouseplatformforepidemiologicalstudiesinhematologicalpatientswithcovid19